Oike F, Talpe S, Otsuka M, Dehoux J P, Lerut J, Otte J B, Gianello P
Laboratory of Experimental Surgery, Université Catholique de Louvain, Brussels, Belgium.
Transplantation. 2000 Jun 15;69(11):2304-14. doi: 10.1097/00007890-200006150-00014.
Spontaneous tolerance to liver allograft has been reported previously in outbred pig models, but the lack of genetic background did not allow to analyze the impact of the major histocompatibility complex (MHC) on tolerance induction. A model of semi-identical liver allograft was therefore developed in inbred miniature swine in order to mimic the clinical situation of living related liver transplant (parent into infant) and to study a protocol for inducing tolerance to liver allograft.
SLAdd (class Id/d, class IId/d) pigs received orthotopic liver allograft from heterozygous SLAcd (class Ic/d, class IIc/d) miniature swine. Eight animals did not receive immunosuppression. Fourteen SLAdd animals had a 12-day course of FK506 and were divided in two subgroups. In subgroup FK-1, six pigs received a daily intramuscular injection of FK506 at 0.1-0.4 mg/kg, in order to reach daily trough levels between 7 and 20 ng/ml; in subgroup FK-2, eight additional animals received two daily injections of FK506 at 0.05 mg/kg regardless of the daily trough levels. Graft survival, liver biological tests, histology, cellular and humoral immune responses, as well as detection of microchimerism were assessed in all groups.
All untreated animals rejected their allograft and died within 28.1 +/- 9.5 days. These rejector animals developed a significant anti-donor cellular and humoral immune response. No peripheral or lymphoid tissue microchimerism was detected in this group. In contrast, long-term survival was obtained in five FK-treated animals (112, 154, 406, 413, and 440 days), whereas several pigs died with a normal allograft function from either overimmunosuppression or intercurrent causes. All FK-treated pigs developed a specific anti-donor unresponsiveness in both cell mediated lymphocytotoxicity and mixed lymphocyte reaction and did not develop anti-donor alloantibodies. The study of the anti-donor immune response by mixed lymphocyte reaction, during the first postoperative week, demonstrated a specific anti-donor unresponsiveness in the peripheral blood from the first posttransplant day. Although microchimerism was detectable in the peripheral blood for several postoperative weeks (maximum 10 weeks) in FK-treated animals, donor cells or DNA were not detected during the long-term follow-up in peripheral blood or lymphoid tissues.
Spontaneous tolerance to semi-identical orthotopic liver allograft did not occur, whereas a 12-day course of FK506 allowed long-term graft acceptance. All FK-treated animals developed in vitro signs of specific immune unresponsiveness and transient peripheral microchimerism. The specific anti-donor cellular unresponsiveness occurred on the first postoperative day after surgery and was of long-term duration. The study of the early immunological events in this model could be of major importance regarding clinical living related liver transplantation.
此前在远交猪模型中已报道对肝移植的自发耐受,但缺乏遗传背景使得无法分析主要组织相容性复合体(MHC)对耐受诱导的影响。因此,在近交小型猪中建立了半同基因肝移植模型,以模拟亲属活体肝移植(亲体到婴儿)的临床情况,并研究诱导肝移植耐受的方案。
SLAdd(I类d/d,II类d/d)猪接受来自杂合子SLAcd(I类c/d,II类c/d)小型猪的原位肝移植。8只动物未接受免疫抑制。14只SLAdd动物接受了为期12天的FK506治疗,并分为两个亚组。在FK-1亚组中,6只猪每天肌肉注射0.1 - 0.4 mg/kg的FK506,以使每日谷浓度达到7至20 ng/ml;在FK-2亚组中,另外8只动物每天注射两次0.05 mg/kg的FK506,而不考虑每日谷浓度。评估了所有组的移植物存活、肝脏生物学检测、组织学、细胞和体液免疫反应以及微嵌合体的检测情况。
所有未治疗的动物均排斥其移植物,并在28.1±9.5天内死亡。这些排斥动物产生了显著的抗供体细胞和体液免疫反应。该组未检测到外周或淋巴组织微嵌合体。相比之下,5只接受FK治疗的动物获得了长期存活(112、154、406、413和440天),而几只猪因免疫抑制过度或并发原因在移植物功能正常时死亡。所有接受FK治疗的猪在细胞介导的淋巴细胞毒性和混合淋巴细胞反应中均表现出对供体的特异性无反应,且未产生抗供体同种抗体。术后第一周通过混合淋巴细胞反应研究抗供体免疫反应,结果显示从移植后第一天起外周血中就存在对供体的特异性无反应。尽管在接受FK治疗的动物术后数周(最长10周)外周血中可检测到微嵌合体,但在长期随访中,外周血或淋巴组织中未检测到供体细胞或DNA。
对半同基因原位肝移植未发生自发耐受,而为期12天的FK506治疗可使移植物长期存活。所有接受FK治疗的动物均出现了体外特异性免疫无反应和短暂的外周微嵌合体迹象。特异性抗供体细胞无反应在术后第一天出现且持续时间较长。对该模型早期免疫事件的研究对于亲属活体肝移植临床应用可能具有重要意义。